Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormonal therapy in prostatic carcinoma.

M I Resnick

    Urology
    |November 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Androgen deprivation therapy is a standard treatment for metastatic prostate cancer, with 70-80% of patients responding positively. Early intervention improves outcomes for this androgen-dependent cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.

    The Journal of urology·2008
    Same author

    Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial.

    Prostate cancer and prostatic diseases·2007
    Same author

    Experimental rodent models of prostatitis: limitations and potential.

    Prostate cancer and prostatic diseases·2007
    Same author

    Fibrous inflammatory pseudotumor of the bladder.

    Reviews in urology·2006
    Same author

    Therapeutic strategies for localized prostate cancer I: surgery, ultrasound, adjuvant and neoadjuvant therapy.

    Reviews in urology·2006
    Same author

    What is sexual medicine?

    International journal of impotence research·2005
    Same journal

    "Editorial Comment on "Vaginal Estrogen Prescription is Associated with Reduced Rates of Serious Adverse Outcomes in Women of All Age Groups With Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis".

    Urology·2026
    Same journal

    The True Oral History of Buccal Mucosal Grafts for Male Urethral Stricture Repair.

    Urology·2026
    Same journal

    Preventing Postpartum Pelvic Floor Dysfunction: Clinical Evidence and Policy Gaps in U.S. Coverage of Pelvic Floor Muscle Therapy.

    Urology·2026
    Same journal

    Editorial Comment on "Through the Eyes of the Applicant: A Qualitative Study of the Urology Residency Match".

    Urology·2026
    Same journal

    Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

    Urology·2026
    Same journal

    Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

    Urology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Endocrinology

    Background:

    • Metastatic prostate cancer at diagnosis is common.
    • Endocrine manipulation, specifically androgen deprivation, has been the cornerstone of treatment since the 1940s.

    Purpose of the Study:

    • To review the efficacy and modalities of hormonal therapy for metastatic prostate cancer.
    • To highlight the benefits of early intervention with androgen deprivation therapy.

    Main Methods:

    • Review of established endocrine manipulation strategies for prostate cancer.
    • Discussion of various hormonal therapy options including estrogen, bilateral orchiectomy, antiandrogens, progestational agents, androgen-synthesis inhibitors, and GnRH analogues.

    Main Results:

    • Hormonal therapy achieves positive clinical response in 70-80% of patients.

    Related Experiment Videos

  • Benefits include tumor shrinkage, decreased serum acid phosphatase, pain relief, improved urinary flow, and enhanced well-being.

    • Conclusions:

    • Androgen deprivation therapy is effective for metastatic prostate cancer.
    • Early initiation of hormonal therapy increases the likelihood of positive response due to androgen dependency.
    • Gonadotropin-releasing hormone analogues show promise with potentially fewer side effects.